PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21414183-1	2011	AIM: To test the hypothesis that myoinositol supplementation will improve insulin sensitivity as measured by markers of insulin resistance such as homeostasis model assessment of insulin resistance and adiponectin in women with gestational diabetes.	Inositol	33-44	adiponectin, C1Q and collagen domain containing	Homo sapiens	202-213	
34665453-1	2022	PURPOSE: To compare the effects of insulin sensitizers metformin (MET) and myo-inositol (MI) on adiponectin levels and metabolic characteristics in women with polycystic ovary syndrome (PCOS) with respect to their body mass index (BMI).	Inositol	75-87	adiponectin, C1Q and collagen domain containing	Homo sapiens	96-107	
21414183-8	2011	Adiponectin increased in the myoinositol group while it decreased in the control group (P = 0.009).	Inositol	29-40	adiponectin, C1Q and collagen domain containing	Homo sapiens	0-11